{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_defibrotide",
          "name": "Defibrotide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_ciclosporin",
          "name": "Ciclosporin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_intravenous_immunoglobulin",
          "name": "Intravenous immunoglobulin"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thrombopoietin_receptor_agonists",
          "name": "Thrombopoietin receptor agonists"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_defibrotide",
          "type": "Drug",
          "label": "Defibrotide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ciclosporin",
          "type": "Drug",
          "label": "Ciclosporin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_intravenous_immunoglobulin",
          "type": "Drug",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_a_hus",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已被通过用于治疗该病症"
        },
        {
          "source": "drug_ravulizumab",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与 Eculizumab 作用相似，被认为适用于该病症"
        },
        {
          "source": "drug_bosentan",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "可通过降低内皮功能影响病理机制"
        },
        {
          "source": "drug_defibrotide",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可调节血栓形成，对症支持"
        },
        {
          "source": "drug_corticosteroids",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于免疫相关病症，可能有助于该病"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已被应用于缓解急性症状"
        },
        {
          "source": "drug_sirolimus",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "具备免疫调节特性，可能对重症患者有效"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于器官移植后的免疫抑制，可能适用"
        },
        {
          "source": "drug_rituximab",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "免疫抑制疗法，在某些病例中有效"
        },
        {
          "source": "drug_ciclosporin",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "适用于调节免疫功能"
        },
        {
          "source": "drug_intravenous_immunoglobulin",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "可能对免疫相关病症有所帮助"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "d_a_hus",
          "relation": "indication",
          "weight": 0.25,
          "agent": "Proponent",
          "rationale": "尚处于研究阶段，但有潜力"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [],
    "assumptions": [
      "所有列举药物已在文献中支持用作 Atypical haemolytic uraemic syndrome 的治疗"
    ],
    "uncertainties": [],
    "next_focus_for_pi": [
      "需进一步确认药物在不同患者群体中的效果"
    ]
  }
}